Aspire-Lakewood Holdings ASBP
NASDAQ ASBP
$8.85 +0.13 (+1.49%)
At close: Oct 21, 2026 · 4:00 PM EDT

Aspire Biopharma Holdings, Inc. (ASBP) EBT (2024 - 2026)

Updated

Aspire Biopharma Holdings (ASBP) reported EBT of -$1.27 million for Q2 2026, compared with -$1.98 million a year earlier.

Analysis

Aspire Biopharma Holdings, Inc. (ASBP) EBT (2024 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Aspire Biopharma Holdings' EBT came in at -$15.2 million; for FY2025, it came in at -$24.48 million.

  • By year, EBT came in at -$1.31 million in FY2024 and -$358,589 in FY2023.
  • The Q2 2026 figure ranks as the highest quarterly EBT since Q4 2024.
  • Per Business Quant data, the three quarters before Q2 2026 came in at -$3.22 million (Q1 2026), -$8.08 million (Q4 2025) and -$2.63 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.27 Mn
Mar 31, 2026 -3.22 Mn
Dec 31, 2025 -8.08 Mn
Sep 30, 2025 -2.63 Mn
Jun 30, 2025 -1.98 Mn
Mar 31, 2025 -15.94 Mn
Dec 31, 2024 -667,722.00
Sep 30, 2024 -215,256.00
API Access

Aspire Biopharma Holdings, Inc. EBT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt&ticker=ASBP&period=max&api_key=YOUR_API_KEY